Madrigal Pharmaceuticals, Inc. (MDGL): Cash & Equivalents
$198.69M
As of 2025-12-31
$292.73M
As of 2026-06-30
-15.7%
3-year compound annual growth
+29.8%
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $198.69M | +98.7% | 2026-02-19, Balance as of period end |
| 2024-12-31 | $100.02M | +0.1% | 2026-02-19, Balance as of period end |
| 2023-12-31 | $99.92M | -69.9% | 2025-02-26, Balance as of period end |
| 2022-12-31 | $331.55M | +814.1% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $36.27M | -32.8% | 2023-03-03, Balance as of period end |
| 2020-12-31 | $54.00M | +15.6% | 2022-02-24, Balance as of period end |
| 2019-12-31 | $46.70M | -18.6% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $57.38M | -61.4% | 2020-02-26, Balance as of period end |
| 2017-12-31 | $148.63M | +676.3% | 2019-02-27, Balance as of period end |
| 2016-12-31 | $19.14M | n/m | 2018-03-13, Balance as of period end |
| 2015-12-31 | $306.2K | -99.3% | 2017-03-31, Balance as of period end |
| 2014-12-31 | $46.02M | -5.1% | 2016-03-15, Balance as of period end |
| 2013-12-31 | $48.49M | -40.5% | 2016-03-15, Balance as of period end |
| 2012-12-31 | $81.51M | +171.0% | 2015-03-12, Balance as of period end |
| 2011-12-31 | $30.07M | -3.9% | 2014-03-11, Balance as of period end |
| 2010-12-31 | $31.31M | -29.1% | 2013-03-14, Balance as of period end |
| 2009-12-31 | $44.16M | n/a | 2012-02-22, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $198.69M | +98.7% |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $372.26M | +53.8% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $285.58M | +97.1% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $752.50M | +66.1% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $177.69M | -44.4% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $63.87M | -34.8% |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $231.25M | +227.7% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $120.50M | -5.6% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $205.40M | +106.4% |
Compare MDGL, IONS, ANIP, HRMY side by side · Screen every company in Pharmaceutical Preparations ↗